Cite
HARVARD Citation
Migliorini, D. et al. (n.d.). P01.122 Safety, immunogenicity and optimization of the IMA950 multipeptide vaccine combined with Poly-ICLC in newly diagnosed HLA-A2 malignant glioma patients. Neuro-oncology. p. iii260. [Online].